SICKLE CELL DISEASE (SCD)
Clinical trials for SICKLE CELL DISEASE (SCD) explained in plain language.
Never miss a new study
Get alerted when new SICKLE CELL DISEASE (SCD) trials appear
Sign up with your email to follow new studies for SICKLE CELL DISEASE (SCD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with sickle cell pain
Disease control CompletedThis study tested the safety and correct dosing of a drug called crizanlizumab in children aged 2 to 18 with sickle cell disease. The goal was to see if the drug, given as a monthly infusion, could safely reduce the frequency of painful vaso-occlusive crises. Researchers studied …
Matched conditions: SICKLE CELL DISEASE (SCD)
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug safety checked for indian sickle cell patients
Disease control CompletedThis study checked the safety of crizanlizumab, a medication that helps reduce painful crises in sickle cell disease. It involved 140 Indian patients aged 16 and older who had experienced these painful episodes before. Researchers monitored patients for side effects while they re…
Matched conditions: SICKLE CELL DISEASE (SCD)
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC